European Union Member States have had a sluggish start to their vaccination campaigns after the European Commission gave the green light in December to the vaccine marketed by the BioNTech and Pfizer alliance. As of 4 January, only a few hundred thousand people had received their first dose across the EU, with wide variations evident between countries.
These figures contrast with those of China, the United States and Israel, who have already administered several million doses.
Facing...